📈 Economy
Hit
✦ AI
Eurostat published the June 2026 flash CPI on July 1, 2026: 2.8% YoY (down from 3.2% in May). Energy remains the key driver at +8.7%. The Strait of Hormuz crisis (Brent +5% weekly from July) is likely to keep the energy component elevated in July rather than letting it fall further. Energy CPI responds with a 4–6 week lag to crude oil moves. Services inflation was 3.2% in June, expected to decline gradually. A further drop below 2.5% in July appears unlikely. The ECB hiked to 2.25% in June 2026 — a further signal of persistent inflation. No Polymarket market found.
📈 Economy
Hit
✦ AI
EUR/USD was at 1.1411 on July 10–11 (exchange-rates.org). A drop below 1.1350 would require a decline of -0.5%. Downside risks: Fed Chair Warsh delivers his first semi-annual congressional testimony on July 14–15 — markets are already pricing a possible rate hike as early as September 2026 (CNBC, July 10, 2026); hawkish language would strengthen the dollar. Countervailing factor: US June CPI (July 14) is estimated at ~3.7–3.8% YoY (Octagon AI), declining from 4.2%, which may reduce the urgency for further Fed action. On net, 1.1350 appears a robust support with ~75% probability of holding.
🏛️ Politics
✦ AI
Polymarket assigns 83% probability to Democratic control of the House as of July 12, 2026. The Democratic generic ballot lead stands at 5–6 points in June 2026 polls, consistent with historical midterm patterns under Republican presidents. Historically, the president's party loses an average of 26 House seats — Democrats would need fewer than ~20 net gains. Gerrymandering could dampen the effect. This scenario (Democrats in the House, Republicans in the Senate) would be a classic split Congress — consistent with the open platform prediction that Republicans retain the Senate.
📈 Economy
Hit
✦ AI
J&J reports Q2-2026 results on July 15, 2026 before market open. Analyst consensus (Benzinga, TipRanks): ~$2.85 adjusted EPS (vs. $2.77 prior year, +2.9% YoY). J&J has beaten EPS consensus in 20+ consecutive quarters. Benzinga analysis July 11, 2026: 'Likely To Report Higher Q2 Earnings.' No dedicated Polymarket/Kalshi market. Key drivers: pharma (Tremfya, Darzalex, Tecvayli), MedTech recovery. Revenue consensus: ~$25.02B. Historical beat rate >75% supports another upside.
📈 Economy
Hit
✦ AI
BlackRock reports Q2-2026 results on July 15 before market open. Consensus: ~$12.54–12.63 adjusted EPS. Benzinga shows Earnings ESP of +1.21% – a classic upside signal. No dedicated Polymarket/Kalshi market. Drivers: AUM growth from S&P 500 rally above 7,700, revenue est. +24.5% YoY to ~$6.75B. Alternatives strengthened by HPS Investment Partners integration (Jan 2025). BLK historically beats consensus in 4 of 5 quarters.
⚽ Sports
Hit
✦ AI
Mads Pedersen leads the Tour de France 2026 points classification after 9 stages by ~75–80 points over the next sprinter. He won Stage 4, collected at intermediate sprints (Bordeaux, Bergerac), and defended the jersey confidently. Remaining sprint stages (11: July 15 Vichy–Nevers; 12: July 16; 17: July 22 Chambéry–Voiron) offer more opportunities. In Alpine summit finishes (Stages 18–20) he concedes few points. No Polymarket/Kalshi market. Only remaining risk: DNF due to crash or illness.
🍾 Beverages
Hit
✦ AI
Pernod Ricard (FY ending June 30, 2026) labeled FY2026 a 'transition year' and guided to -3% to -4% organic net sales decline. H1 FY26 (July–Dec 2025) was heavily negative – China at -21% organic. Q3 FY26 (Jan–Mar 2026) recovered to +4.1%, insufficient to pull the full-year above -2%. S&P Global Ratings revised its outlook on Pernod Ricard. No Polymarket/Kalshi market. FY2026 annual results published October 16, 2026 at 9:00 AM CEST (MarketScreener). Residual risk: unexpectedly strong Q4 (April–June 2026) might limit the decline to just below -2%.
📈 Economy
Hit
✦ AI
Citigroup reports Q2 2026 before market open on July 14. Wall Street consensus stands at $2.67–2.72 adjusted EPS per Alphastreet/Hudson Labs, implying roughly +35% YoY growth. The macro environment (elevated rates, strong trading revenues) structurally favored large US banks in H1 2026. JPMorgan, Goldman Sachs, and BofA are already listed as open beat-predictions for the same date; the historical beat rate in US large-cap banking over the last eight quarters exceeds 75%. No Polymarket market available; estimate based on sector analogues.
💻 Technology
Hit
✦ AI
Netflix reports Q2 2026 after market close on July 16. Analyst EPS consensus stands at approximately $0.79 adjusted per Hudson Labs. The stock lost ~20% YTD and recently traded around $73–76 — expectations were already meaningfully revised down, which classically raises the beat probability. Netflix beat EPS in five of the last six quarters; the ad-supported tier and live sports content support subscriber growth and ARPU. No specific prediction market available. A miss is possible if content costs surprised to the upside.
📈 Economy
Hit
✦ AI
Cable (GBP/USD) was trading at 1.3394–1.3449 per Trading Economics on July 10, 2026. A breach of 1.3300 would require a drop of roughly 0.7–1.1% over six trading days. Short-term risks: US CPI on July 14 (open prediction: above 3.5% YoY), strong Retail Sales data (July 16), Fed Chair Warsh testimony (July 15). On the other side: EUR/USD is firm (1.1416), supportive for GBP. Next BoE meeting only July 30, no immediate catalyst for GBP weakness. No specific Polymarket market available.
💻 Technology
Miss
✦ AI
Spotify reports Q2 2026 before market open on August 4. Analyst EPS consensus stands at $3.29 per Benzinga. In Q1 2026, Spotify posted a clear beat ($4.04 vs. $3.72 consensus; +8.6%). Q2 forecasts assume 778M MAUs, ~299M paying subscribers, and gross margin ~33.1%. Operating leverage has risen sharply. Risks: content costs, podcast restructuring. Beat probability based on recent quarterly momentum: 72%. No Polymarket market available.
📈 Economy
Miss
✦ AI
Eli Lilly reports Q2 2026 on August 5. Consensus stands at $8.81–8.85 adjusted EPS per TipRanks. In Q1 2026, Lilly beat by a remarkable 24.8% ($8.55 vs. $6.85 expected), driven by strong tirzepatide (Mounjaro/Zepbound) volumes and sustained GLP-1 demand. Manufacturing capacity was massively expanded in 2025–2026. Risks: US healthcare pricing pressure, potential rebate negotiations. Beat probability: 76%, as consensus estimates after a large Q1 beat tend to lag full ramp-up.
⚽ Sports
Miss
✦ AI
After Stage 9, Vingegaard sits 2nd, 2:42 behind Pogačar. Isaac del Toro (3rd, +3:27) and Remco Evenepoel (4th, +3:30) are the next challengers — their gap to Vingegaard is only 45–48 seconds. Multiple mountain stages remain (incl. Orcières-Merlette, double Alpe d'Huez) plus the ITT (Stage 16, 26.1 km). Vingegaard is a world-class climber and time-trialist; dropping off the podium would require a crash, illness, or several days of poor form. No explicit prediction market for Vingegaard podium available.